Ibuvit D3 4000 IU 60 capsules

Directions for use: Use as directed by your doctor
Detailed instructions for use can be found in the leaflet enclosed in the package.

Storage: Store at room temperature

Colecalciferol

Zakłady Farmaceutyczne Polpharma S.A.

Zakłady Farmaceutyczne Polpharma S.A.,
ul. Pelplińska 19,
83-200 Starogard Gdański,
PL

The total dose of vitamin D in patients consists of the content of vitamin D in other medicinal products taken and consumed foods rich in vitamin D, as well as the vitamin produced by the body as a result of exposure to sunlight. In Poland, sufficient exposure to sunlight is only possible from May to September and requires at least 15 minutes of sun exposure daily between 10:00 and 15:00, with exposed forearms and lower legs, without using creams with UV filters. Vitamin D should be used with caution in patients with impaired renal function and its effect on calcium and phosphorus levels should be monitored. The risk of soft tissue calcification should be taken into account. In patients with impaired renal function treated with Ibuvit D3, calcium and phosphate metabolism parameters should be monitored. Caution is necessary in patients receiving treatment for cardiovascular disease (see section 4.5 - cardiac glycosides, including digitalis). Vitamin D should be used with caution in patients with sarcoidosis due to the risk of increased conversion of vitamin D to its active form.In these patients, serum and urine calcium levels should be monitored. Patients taking other medications, dietary supplements containing vitamin D (cholecalciferol), calcitriol or other metabolites or analogues of vitamin D should consult a doctor before taking Ibuvit D3 to select the appropriate dose. Patients with obesity (adults - BMI ≥ 30 require twice the dose of vitamin D than recommended for their peers with a normal body weight. There is insufficient data on the effect of vitamin D administration on the formation of kidney stones, although such a risk is possible, especially in the case of additional calcium supplementation. The need for additional calcium supplementation should be considered individually. The concentration of calcium in serum and urine should be monitored. In the case of long-term use of vitamin D, especially daily doses significantly exceeding the recommended doses, the concentration of calcium in serum and urine should be monitored and renal function should be monitored by measuring creatinine concentration. This is particularly important in the case of elderly patients and in the case of concomitant treatment with cardiac glycosides or thiazide diuretics that reduce the excretion of calcium in urine.